Clinical Trials
2 trialsNCT01676805 2026-05-05
Tissue Collection for Studies of Lymph Cancer
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02924402 2024-11-13
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
Xencor, Inc.
Phase 1 Completed